General Statement of Disclosure:
OTHER FINANCIAL BENEFIT: Medtronic(NONE), Amgen Inc.(NONE), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Novartis(MODEST), Servier(MODEST), Vifor(NONE), Bayer(SIGNIFICANT)
OTHER FINANCIAL BENEFIT: Medtronic(NONE), Amgen Inc.(NONE), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Novartis(MODEST), Servier(MODEST), Vifor(NONE), Bayer(SIGNIFICANT)
© 2025 American College of Cardiology Foundation. All rights reserved.